SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990, Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990.Right pointing arrow large image Go to www.irs.gov/Form990 for instructions and the latest information.
OMB No. 1545-0047
2021
Open to Public Inspection
Name of the organization
JDRF INTERNATIONAL
 
Employer identification number

23-1907729
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? . . . . . . . . . . . . . . . . . . . . . . . . .
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in the region (d) Activities conducted in region (by type) (such as, fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in the region		 (f) Total expenditures
for and investments
in the region
EAST ASIA AND THE PACIFIC     GRANTMAKING RESEARCH GRANTS 5,016,705
NORTH AMERICA     GRANTMAKING RESEARCH GRANTS 3,825,650
EUROPE     GRANTMAKING RESEARCH GRANTS 11,420,906
MIDDLE EAST AND NORTH AFRICA     GRANTMAKING RESEARCH GRANTS 2,274,996
SOUTH ASIA     GRANTMAKING RESEARCH GRANTS 200,000
EUROPE   2 PROGRAM SERVICES RESEARCH SUPPORT 294,361
EUROPE     INVESTMENTS INVESTMENTS 3,431,835
NORTH AMERICA     INVESTMENTS INVESTMENTS 3,020,423
           
           
           
           
           
           
           
           
           
3a Sub-total .... 0 2 29,484,876
b Total from continuation sheets to Part I ... 0 0 0
c Totals (add lines 3a and 3b) 0 2 29,484,876
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2021
Page 2
Schedule F (Form 990) 2021
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of noncash
assistance 		(h) Description
of noncash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
EUROPE (INCLUDING ICELAND AND GREENLAND) METABOLIC CONTROL 81,635 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 50,000 CHECK/WIRE TRANSFER 0 N/A N/A
SOUTH ASIA METABOLIC CONTROL 200,000 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 917,181 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA PREVENTION 297,815 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC MISSION 800,000 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) TRANSPORTFOLIO 56,330 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) TRANSPORTFOLIO 94,418 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC IMMUNOTHERAPIES 109,278 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 366,430 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REGENERATION 325,000 CHECK/WIRE TRANSFER 0 N/A N/A
MIDDLE EAST AND NORTH AFRICA COMPLICATIONS 360,000 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 149,963 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA METABOLIC CONTROL 100,967 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 218,660 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 126,500 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REGENERATION 499,448 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) TRANSPORTFOLIO 465,000 CHECK/WIRE TRANSFER 0 N/A N/A
MIDDLE EAST AND NORTH AFRICA TRANSPORTFOLIO 833,060 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) METABOLIC CONTROL 2,024,922 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 609,520 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 51,477 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) METABOLIC CONTROL 100,000 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA ARTIFICIAL PANCREAS 336,087 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REPLACEMENT 54,419 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 99,928 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC IMMUNOTHERAPIES 300,000 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC BETA CELL REGENERATION 109,919 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC IMMUNOTHERAPIES 100,000 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PSYCHOSOCIAL 574,929 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 424,616 CHECK/WIRE TRANSFER 0 N/A N/A
MIDDLE EAST AND NORTH AFRICA ARTIFICIAL PANCREAS 156,936 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC BETA CELL REPLACEMENT 95,100 CHECK/WIRE TRANSFER 0 N/A N/A
MIDDLE EAST AND NORTH AFRICA PREVENTION 775,000 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 181,160 CHECK/WIRE TRANSFER 0 N/A N/A
MIDDLE EAST AND NORTH AFRICA PREVENTION 150,000 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 374,927 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC IMMUNOTHERAPIES 1,635,568 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 162,520 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 410,000 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 497,585 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA PSYCHOSOCIAL 566,484 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC COMPLICATIONS 499,999 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC PREVENTION 38,837 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REPLACEMENT 647,599 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REGENERATION 349,264 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) COMPLICATIONS 117,473 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA BETA CELL REPLACEMENT 262,535 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) COMPLICATIONS 472,642 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 1,012,196 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) METABOLIC CONTROL 200,816 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) IMMUNOTHERAPIES 70,000 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC PREVENTION 289,620 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 900,000 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REPLACEMENT 60,038 CHECK/WIRE TRANSFER 0 N/A N/A
NORTH AMERICA ARTIFICIAL PANCREAS 423,091 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) BETA CELL REGENERATION 63,131 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) PREVENTION 399,851 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC PREVENTION 296,077 CHECK/WIRE TRANSFER 0 N/A N/A
EUROPE (INCLUDING ICELAND AND GREENLAND) ARTIFICIAL PANCREAS 50,000 CHECK/WIRE TRANSFER 0 N/A N/A
EAST ASIA AND THE PACIFIC METABOLIC CONTROL 742,308 CHECK/WIRE TRANSFER 0 N/A N/A
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .......MediumBullet
0
3 Enter total number of other organizations or entities .......................MediumBullet
61
Schedule F (Form 990) 2021
Page 3
Schedule F (Form 990) 2021Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" on Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
noncash
assistance 		(g) Description
of noncash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2021
Page 4
Schedule F (Form 990) 2021
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to separately file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A; don't file with Form 990). . . . . . . . . . . . . . . . . . . . . . . .
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471). . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621) .
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships (see Instructions for Form 8865). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to separately file Form 5713, International Boycott Report (see Instructions for Form 5713; don't file with Form 990).. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Schedule F (Form 990) 2021
Page 5
Schedule F (Form 990) 2021
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information. See instructions.
ReturnReference Explanation
PART I, LINE 2: GRANT MONITORING PROCEDURES RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL ("JDRFI") WITH THE SUPPORT OF JDRFI'S RESEARCH COMMITTEE COMPRISED OF "JDRFI BOARD MEMBERS AND OTHER VOLUNTEERS" FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS.
PART III ACCOUNTING METHOD:  
PART II, LINES 2 AND 3: WHILE MANY FOREIGN GRANTEES MAY BE RECOGNIZED AS CHARITIES IN THEIR RESPECTIVE COUNTRY OR AS 501(C)(3) ORGANIZATIONS BY THE IRS, JDRF DOES NOT HAVE A FEASIBLE WAY TO VALIDATE FOREIGN TAX EXEMPTION AND CONSERVATIVELY CLASSIFIES ALL FOREIGN GRANTS AS OTHER.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2021
Additional Data


Software ID:  
Software Version: